Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in rats
Background: In the last decades different preclinical animal models of Parkinson's disease (PD) have been generated, aiming to mimic the progressive neuronal loss of midbrain dopaminergic (DA) cells as well as motor and non-motor impairment. Among all the available models, AAV-based models of h...
Main Authors: | F. Gubinelli, L. Sarauskyte, C. Venuti, I. Kulacz, G. Cazzolla, M. Negrini, D. Anwer, I. Vecchio, F. Jakobs, F.P. Manfredsson, M. Davidsson, A. Heuer |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Current Research in Neurobiology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2665945X22000389 |
Similar Items
-
Administration of AAV-Alpha Synuclein NAC Antibody Improves Locomotor Behavior in Rats Overexpressing Alpha Synuclein
by: Yun-Hsiang Chen, et al.
Published: (2021-06-01) -
The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
by: Rachel Kelly, et al.
Published: (2021-11-01) -
Aggregation-Inhibiting scFv-Based Therapies Protect Mice against AAV1/2-Induced A53T-α-Synuclein Overexpression
by: Benjamin W. Schlichtmann, et al.
Published: (2023-07-01) -
AAV genome modification for efficient AAV production
by: Walaa Asaad, et al.
Published: (2023-04-01) -
Engineered AAV2.7m8 Serotype Shows Significantly Higher Transduction Efficiency of ARPE-19 and HEK293 Cell Lines Compared to AAV5, AAV8 and AAV9 Serotypes
by: Dzerassa Gurtsieva, et al.
Published: (2024-01-01)